Literature DB >> 18057528

Claudin proteins in ovarian cancer.

Patrice J Morin1.   

Abstract

Members of the claudin family of tight junction proteins have been found altered in several malignancies, including ovarian cancer. Because claudin-3 and -4 are elevated in the vast majority of ovarian tumors, they may represent useful biomarkers for detection and prognosis, as well as ideal targets for therapy using the Clostridium perfringens enterotoxin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057528      PMCID: PMC3851116          DOI: 10.1155/2007/674058

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  9 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

2.  Expression pattern of claudins 1 and 3-an auxiliary tool in predicting behavior of mucoepidermoid carcinoma of salivary gland origin.

Authors:  Katri Aro; Luiz Eduardo Blumer Rosa; Ibrahim O Bello; Ylermi Soini; Antti A Mäkitie; Tuula Salo; Ilmo Leivo
Journal:  Virchows Arch       Date:  2010-12-24       Impact factor: 4.064

3.  Identification of MarvelD3 as a tight junction-associated transmembrane protein of the occludin family.

Authors:  Emily Steed; Nelio T L Rodrigues; Maria S Balda; Karl Matter
Journal:  BMC Cell Biol       Date:  2009-12-22       Impact factor: 4.241

Review 4.  Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin.

Authors:  Miriam Eichner; Jonas Protze; Anna Piontek; Gerd Krause; Jörg Piontek
Journal:  Pflugers Arch       Date:  2016-11-18       Impact factor: 3.657

5.  Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3.

Authors:  Lars Winkler; Claudia Gehring; Ariane Wenzel; Sebastian L Müller; Christian Piehl; Gerd Krause; Ingolf E Blasig; Jörg Piontek
Journal:  J Biol Chem       Date:  2009-05-08       Impact factor: 5.157

6.  Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.

Authors:  Yu-Hung Huang; Yunhua Bao; Weidan Peng; Michael Goldberg; Kevin Love; David A Bumcrot; Geoffrey Cole; Robert Langer; Daniel G Anderson; Janet A Sawicki
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

7.  Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.

Authors:  Neetu Dahiya; Kevin G Becker; William H Wood; Yongqing Zhang; Patrice J Morin
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

Review 8.  On the interaction of Clostridium perfringens enterotoxin with claudins.

Authors:  Anna Veshnyakova; Jonas Protze; Jan Rossa; Ingolf E Blasig; Gerd Krause; Joerg Piontek
Journal:  Toxins (Basel)       Date:  2010-06-08       Impact factor: 4.546

9.  Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.

Authors:  Anna Piontek; Miriam Eichner; Denise Zwanziger; Laura-Sophie Beier; Jonas Protze; Wolfgang Walther; Sarah Theurer; Kurt Werner Schmid; Dagmar Führer-Sakel; Jörg Piontek; Gerd Krause
Journal:  Mol Oncol       Date:  2020-01-08       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.